Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

Lords urge legal use of cannabis

Guardian, The

Thursday 22 Mar 2001

---


Subj: UK: Lords urge legal use of cannabis
Date: Thursday March 22, 2001
Source: Guardian, The


Lords urge legal use of cannabis
Sarah Boseley, health editor
Thursday March 22, 2001


Progress towards a cannabis-based medicine for conditions it
can allegedly help, such as multiple sclerosis, is too slow,
a House of Lords committee said yesterday.

It urged the government to change the law so doctors can
legally prescribe cannabis derivatives as soon as they are
scientifically approved.

The Lords select committee on science and technology has re-
entered the fray after receiving the brush-off from the
government in November 1998, when it recommended that
doctors should be allowed to prescribe cannabis derivatives;
a finding the government rejected.

Yesterday the committee published a ten-page report on the
progress towards producing a legitimate medicine from the
drug.

The Medical Research Council has commissioned two trials
from scientists to establish the principle that cannabis
derivatives can help relieve pain. However, the committee is
concerned that it may take a long time for anything
practical to emerge from trials.

The committee is more encouraged by the progress being made
by the GW Pharmaceuticals, which is about to embark onthe
large-scale trials of cannabis-based treatments.

The report says the government's attitude lately has been
more encouraging, following a period in which it feared that
"permitting therapeutic preparations of cannabis to be
prescribed would be interpreted by the public as a move
towards allowing recreational use".

Lord Perry of Walton, a committee member, said yesterday
that he hoped there might be a cannabis-derived medicine on
the market within two years.

However, he was alarmed by a decision by the licensing body,
the Medicines Control Agency, that past evidence on the
toxicity of the cannabis derivative cannabidiol was not good
enough. Additional testing could slow development of a
licensed medicine by two to three years.



 

 

 

After you have finished reading this article you can click here to go back.




This page was created by the Cannabis Campaigners' Guide.
Feel free to link to this page!